The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper

By AHRMM

In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Data Quality Workshops during four conferences in 2017. During these workshops, conference attendees had the opportunity to voice their opinions on the state of UDI data quality, hurdles to UDI adoption and what recommended practices are necessary for providers and suppliers to effectively capture the UDI and use it in meaningful ways.  

A clear message has emerged from health care stakeholders – the only way to drive greater UDI adoption across the health care field is for the individuals and groups engaged in UDI efforts to collaborate, share their experiences, and learn from each other. In this paper, we leverage these collective insights to present challenges faced by providers and manufacturers today with regards to UDI adoption, and highlight potential solutions that have emerged from the work of the LUC and other health care participants.

 

Related Resources

Guides/Reports
Crossing the Quality Chasm: A New Health System for the 21st Century
Advisory
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Senior Contract Specialist
Senior Contract Specialist job description.
Request for Proposals (RFP)
CT Scanner RFP
A sample of a CT scanner RFP covering all the basics. Download the document and tailor it to your needs.
Advisory
Special Fraud Alert: Physician-Owned Entities
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Advisory
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.